FDA Recalls Jardiance Diabetes Tablets Due to Storage Temperature Deviations
Jardiance 25 mg tablets distributed nationwide were recalled due to CGMP deviations where products were exposed to temperatures outside the labeled storage conditions. The recall affects batch D41919.
- Product
- JARDIANCE — JARDIANCE (EMPAGLIFLOZIN)
- Category
- Drug
- Distribution
- Distributed nationwide